Loree Larratt

5.0k citations
80 papers · 3.2k · 1 hit paper · h-index 28

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.5%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments

Papers in

    • Acute Myeloid Leukemia Research 23
    • Hematopoietic Stem Cell Transplantation 21
    • Chronic Myeloid Leukemia Treatments 6
    • Chronic Lymphocytic Leukemia Research 18

Loree Larratt

77 papers receiving 3.1k citations

Loree Larratt's Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial 2018 · 386 citations
3860+2+5Years since publication100200300

Peers

Loree Larratt
Comparison fields: 5 of 90
  • Genetics 1.2k
  • Hematology 1.1k
  • Pathology and Forensic Medicine 829
  • Immunology 710
  • Transplantation 71
Replace Emilio Montserrat with:
Emilio Montserrat Spain
Amy E. DeZern United States
Yago Nieto United States
Emmanuel Gyan France
Anders Österborg Sweden
Felicetto Ferrara Italy
H M Lokhorst Netherlands
Massimo Gentile Italy
Valérie Gouilleux‐Gruart France
Tibor Kovacsovics United States
Loree Larratt relative to Emilio Montserrat Spain Emilio Montserrat's profile →
Citations per field
00.5×6.6×
Emilio Montserrat · 1×
Citations per year

Countries citing papers authored by Loree Larratt

Since Specialization
Citations

This map shows the geographic impact of Loree Larratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loree Larratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loree Larratt more than expected).

Fields of papers citing papers by Loree Larratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loree Larratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loree Larratt. The network helps show where Loree Larratt may publish in the future.

Co-authors

The 25 scholars most cited alongside Loree Larratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Loree Larratt Line = papers co-authored together Loree Larratt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2018386
2 2010359
3 2003289
4 2007218
5
Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
1984140
6 2005136
7 2009126
8 202098
9 201395
10 198490
11 202283
12 199771
13
Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.
199664
14 200761
15 200760
16 200557
17 200255
18 199853
19 200852
20 200950

About Loree Larratt

Loree Larratt is a scholar working on Hematology, Genetics, Immunology, Public Health, Environmental and Occupational Health and Oncology, having authored 80 papers that have together received 3.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (18 papers), Complement system in diseases (10 papers), Lymphoma Diagnosis and Treatment (7 papers), Polyomavirus and related diseases (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Genetics (1.2k citations), Hematology (1.1k citations), Pathology and Forensic Medicine (829 citations), Immunology (710 citations) and Transplantation (71 citations). Loree Larratt has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Andrew R. Belch, Michael J. Mant, Linda M. Pilarski, Tony Reiman, Brian J. Taylor, Christopher A. Maxwell, Jonathan J. Keats, A. Robert Turner, John G. Gribben and Benjamín Koziner. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Journal of Clinical Oncology and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact